Prostate adenocarcinoma: a new integrated diagnostic approach aimed at the therapeutic choice | Zendy

A. Delle Fave | Zendy; Stefania Erra | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Prostate adenocarcinoma: a new integrated diagnostic approach aimed at the therapeutic choice

Author(s) -

A. Delle Fave,

Stefania Erra

Publication year - 2016

Publication title -

working paper of public health

Language(s) - English

Resource type - Journals

ISSN - 2279-9761

DOI - 10.4081/wpph.2016.6695

Subject(s) - prostate cancer , medicine , prostate , adenocarcinoma , cancer , prostatic adenocarcinoma , oncology , prostate adenocarcinoma , biopsy , presentation (obstetrics) , cd117 , pathology , radiology , biology , genetics , stem cell , cd34

Prostate cancer is different in clinical presentation, histopathological tumor growth, patterns and survival than others cancer. Therefore, individual assessment of a tumor’s aggressive potential is crucial for clinical decision-making in men with prostate cancer. Here we discuss the potential role of ERG and CD117 as a prognostic factors and molecular targets in needle biopsy on prostate cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research